What is the Sorrento Therapeutics Inc. stock price forecast?

Sorrento Therapeutics Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.

What is Sorrento Therapeutics Inc. insider trading activity?

View the latest insider trading data for Sorrento Therapeutics Inc. on Alpha Lenz.

What is Sorrento Therapeutics Inc.'s P/E ratio?

Sorrento Therapeutics Inc.'s P/E ratio is -0.0.

Sorrento Therapeutics Inc.

NASDAQ · SRNE

$0.00

Ask about Sorrento Therapeutics Inc.'s future dividend policy...

Alpha Chat Insight

“Sorrento Therapeutics Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -1904.9%. 3Y revenue CAGR of 26.0% highlights clear growth momentum.”

Ask for details →

Company Overview

SectorUnknown

IndustryUnknown

Company Statistics

FY 2022

Profile

$335.45KMarket Cap

$62.84MRevenue

0.00Shares Out

N/AEmployees

Margins

46.77%Gross

-580.09%EBITDA

-602.33%Operating

-893.95%Pre-Tax

-919.42%Net

Valuation

-0.00P/E

-0.02P/B

0.01EV/Sales

-0.30EV/EBITDA

-0.00P/FCF

Growth (CAGR)

25.98%Rev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-98.96%ROA

-1904.94%ROE

-94.75%ROIC

Financial Health

$23.63MCash & Cash Equivalents

$470.88MNet Debt

-2282.10%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Sorrento Therapeutics Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -1904.9%. 3Y revenue CAGR of 26.0% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Sorrento Therapeutics Inc. (ticker: SRNE) is a company listed on NASDAQ in the Unknown sector (Unknown). Market cap is $335,452.

The current price is $0.001 with a P/E ratio of -0x and P/B of -0.02x.

ROE is -1904.94% and operating margin is -602.33%. Annual revenue is $63M.